2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
8
Neoplasms
7
Uterine Cervical Neoplasms
5
Head and Neck Neoplasms
5
Prostatic Neoplasms
4
Melanoma
4
Glioblastoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Hematologic Neoplasms
3
Glioma
3
Brain Neoplasms
3
Uterine Cervical Dysplasia
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neuroblastoma
2
Lymphedema
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Squamous Cell
2
Atypical Squamous Cells of the Cervix
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Interventions
Cytarabine
561
Azacitidine
385
venetoclax
311
Cyclophosphamide
289
fludarabine
246
fludarabine phosphate
229
Decitabine
187
Busulfan
176
Daunorubicin
155
Idarubicin
151
Peripheral Blood Stem Cell Transplantation
138
Mycophenolic Acid
134
Filgrastim
134
Whole-Body Irradiation
133
Tacrolimus
125
Granulocyte Colony-Stimulating Factor
124
Etoposide
117
Mitoxantrone
103
Methotrexate
103
Melphalan
103
Cyclosporine
101
Antilymphocyte Serum
85
Gemtuzumab
84
Clofarabine
84
Specimen Handling
73
Injections
69
Stem Cell Transplantation
64
Biopsy
57
CPX-351
56
Thiotepa
54
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
Restraint, Physical
×
Clear all
NCT06786897
2025-01-22
ERAPH
University Hospital, Montpellier
Not yet recruiting
37 enrolled